AU7684798A - Compounds that inhibit the binding of vascular endothelial growth factor to its receptors - Google Patents

Compounds that inhibit the binding of vascular endothelial growth factor to its receptors

Info

Publication number
AU7684798A
AU7684798A AU76847/98A AU7684798A AU7684798A AU 7684798 A AU7684798 A AU 7684798A AU 76847/98 A AU76847/98 A AU 76847/98A AU 7684798 A AU7684798 A AU 7684798A AU 7684798 A AU7684798 A AU 7684798A
Authority
AU
Australia
Prior art keywords
receptors
inhibit
binding
compounds
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76847/98A
Inventor
Ronald J. Biediger
Robert V. Market
Ian L Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encysive Pharmaceuticals Inc
Original Assignee
Texas Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas Biotechnology Corp filed Critical Texas Biotechnology Corp
Publication of AU7684798A publication Critical patent/AU7684798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU76847/98A 1997-05-30 1998-06-01 Compounds that inhibit the binding of vascular endothelial growth factor to its receptors Abandoned AU7684798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4810597P 1997-05-30 1997-05-30
US60048105 1997-05-30
PCT/US1998/009366 WO1998053790A2 (en) 1997-05-30 1998-06-01 Compounds that inhibit the binding of vascular endothelial growth factor to its receptors

Publications (1)

Publication Number Publication Date
AU7684798A true AU7684798A (en) 1998-12-30

Family

ID=21952761

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76847/98A Abandoned AU7684798A (en) 1997-05-30 1998-06-01 Compounds that inhibit the binding of vascular endothelial growth factor to its receptors

Country Status (2)

Country Link
AU (1) AU7684798A (en)
WO (1) WO1998053790A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3111700A (en) * 1998-12-04 2000-06-19 Structural Bioinformatics Inc. Methods and compositions for treating inflammatory diseases utilizing inhibitorsof tumor necrosis factor activity
ATE240310T1 (en) * 1998-12-14 2003-05-15 Vertex Pharma San Diego Llc OPTICAL MOLECULAR SENSORS FOR CYTOCHROME P-450 ACTIVITY
US6420130B1 (en) 1998-12-14 2002-07-16 Aurora Biosciences Corporation Optical molecular sensors for cytochrome P450 activity
AU7961800A (en) * 1999-10-28 2001-05-08 Kyowa Hakko Kogyo Co. Ltd. Thiazolidinedione derivatives
FR2845000B1 (en) * 2002-09-27 2005-05-27 Oreal USE OF A HETEROCYCLIC COMPOUND OR ONE OF ITS SALTS FOR STIMULATING OR INDUCING THE GROWTH OF HAIR AND / OR BRAKING THEIR FALL
AU2003291024A1 (en) * 2002-11-13 2004-06-03 Rigel Pharmaceuticals, Inc. Rhodanine derivatives and pharmaceutical compositions containing them
FI20041129A0 (en) * 2004-08-30 2004-08-30 Ctt Cancer Targeting Tech Oy Thioxothiazolidinone compounds for use as drugs
ITMI20042475A1 (en) * 2004-12-23 2005-03-23 Cell Therapeutics Europe Srl USE OF THIAZOLIDINONIC DERIVATIVES AS THERAPEUTIC AGENTS
WO2007059195A1 (en) * 2005-11-14 2007-05-24 University Of Southern California Integrin-binding small molecules
EP1916249A1 (en) * 2006-10-10 2008-04-30 LEK Pharmaceuticals D.D. 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
CN115636827A (en) * 2022-10-27 2023-01-24 德州学院 Preparation of aggregation-induced emission material and application of aggregation-induced emission material in photodynamic therapy and biological imaging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885369A (en) * 1987-11-30 1989-12-05 Mita Industrial Co., Ltd. Photoconductive material for electrophotography comprising rhodanine derivative charge complex
US5208250A (en) * 1988-05-25 1993-05-04 Warner-Lambert Company Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
FR2680512B1 (en) * 1991-08-20 1995-01-20 Adir NOVEL 2,4-THIAZOLIDINEDIONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
WO1998053790A2 (en) 1998-12-03
WO1998053790A3 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
AU5990296A (en) Coatable biocidal compositions
AU2512995A (en) Multifunctional biodispersant/biocidal compositions
AU6980098A (en) Adhesive composition or structure
AU3044197A (en) Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
AU5674696A (en) Compounds that bind to p185 and methods of using the same
AU5439998A (en) Vascular endothelial growth factor
AU8381498A (en) Novel substituted imidazole compounds
AU8263298A (en) Hot-melt adhesive composition
AUPO705697A0 (en) Dehydration plant
AU2930597A (en) Salt compositions
AU5574898A (en) Hot-melt adhesive composition
EP1062319A4 (en) Vascular endothelial growth factor 2
AU5870996A (en) Dual functional cytotoxic/radiosensitizer compounds and meth ods for the preparation thereof
AU8381298A (en) Novel substituted imidazole compounds
AU5023300A (en) Vascular endothelial growth factor variants
AU2872795A (en) Inhibition of platelet binding
GB9601978D0 (en) Application of materials to substrates
AU7684798A (en) Compounds that inhibit the binding of vascular endothelial growth factor to its receptors
AU7461496A (en) Alpha-olefin adhesive compositions
AU5026100A (en) Vascular endothelial growth factor dimers
AU4027797A (en) Biocidal compositions
AU6522098A (en) Composition containing dithiocarbonate compound
AU6040398A (en) Fungicidal compositions
AU7522898A (en) Pseudo-peptide compounds as antagonists of neurokinines
AU7752698A (en) Method for the synthesis of anti-microbial hydroxybenzoats

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase